Vicus Capital Purchases Shares of 382 Axon Enterprise, Inc $AXON

Key Points

• Vicus Capital has acquired a new stake in Axon Enterprise, purchasing 382 shares valued at approximately $316,000, according to their recent SEC filing.
• CEO Patrick W. Smith sold 10,000 shares of Axon stock for about $8.3 million, representing a 0.33% decrease in his ownership.
• Axon reported earnings of $2.12 per share, exceeding estimates, with a revenue of $668.54 million, up 32.6% from the previous year.

Vicus Capital purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 382 shares of the biotechnology company's stock, valued at approximately $316,000.

Several other large investors have also modified their holdings of the company. TCI Wealth Advisors Inc. acquired a new position in Axon Enterprise during the 2nd quarter worth $214,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Axon Enterprise in the first quarter valued at about $1,110,000. Quotient Wealth Partners LLC bought a new position in shares of Axon Enterprise in the first quarter worth about $438,000. CX Institutional acquired a new position in shares of Axon Enterprise during the 1st quarter worth about $115,000. Finally, GAMMA Investing LLC boosted its stake in Axon Enterprise by 11.8% during the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company's stock valued at $765,000 after purchasing an additional 154 shares during the period. 79.08% of the stock is owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, August 11th. The stock was sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the completion of the transaction, the chief executive officer directly owned 3,053,982 shares of the company's stock, valued at approximately $2,538,744,696.78. This trade represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Brittany Bagley sold 5,000 shares of the business's stock in a transaction on Monday, September 29th. The shares were sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares in the company, valued at $66,813,456.96. This represents a 5.07% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 49,932 shares of company stock worth $37,978,216 over the last three months. 4.40% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

AXON has been the topic of several recent analyst reports. JMP Securities reaffirmed a "market outperform" rating and issued a $825.00 price target on shares of Axon Enterprise in a research report on Monday. Bank of America boosted their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Needham & Company LLC reissued a "buy" rating and issued a $870.00 price target on shares of Axon Enterprise in a report on Wednesday, September 24th. Zacks Research downgraded shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday, September 2nd. Finally, Northland Securities set a $800.00 target price on shares of Axon Enterprise in a research note on Tuesday, August 5th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $841.64.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $720.53 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The company has a 50-day moving average of $758.18 and a 200-day moving average of $706.15. Axon Enterprise, Inc has a 52 week low of $403.16 and a 52 week high of $885.91. The company has a market capitalization of $56.56 billion, a price-to-earnings ratio of 177.91, a PEG ratio of 27.62 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company's quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.